ABIN265241
antibody from antibodies-online
Targeting: SET
2PP2A, IGAAD, IPP2A2, PHAPII, TAF-I, TAF-IBETA
Antibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN265241 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-SET Nuclear Oncogene (SET) antibody
- Antibody type
- Polyclonal
- Antigen
- Synthetic peptide derived from the human SET protein
- Description
- Affinity chromatography
- Reactivity
- Human
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 10 blots
- Storage
- Store the product (in aliquots) at -20°C to -70°C. Can be shipped at 2 - 8°C.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Particle size distributions and health-related exposures of polychlorinated dibenzo-p-dioxins and dibenzofurans (PCDD/Fs) of sinter plant workers.
Inhibitors of protein phosphatase-2A from human brain structures, immunocytological localization and activities towards dephosphorylation of the Alzheimer type hyperphosphorylated tau.
Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor.
Identification and characterization of SEB, a novel protein that binds to the acute undifferentiated leukemia-associated protein SET.
Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein.
Molecular identification of I1PP2A, a novel potent heat-stable inhibitor protein of protein phosphatase 2A.
Replication factor encoded by a putative oncogene, set, associated with myeloid leukemogenesis.
Can, a putative oncogene associated with myeloid leukemogenesis, may be activated by fusion of its 3' half to different genes: characterization of the set gene.
Shih TS, Shih M, Lee WJ, Huang SL, Wang LC, Chen YC, Tsai PJ
Chemosphere 2009 Mar;74(11):1463-70
Chemosphere 2009 Mar;74(11):1463-70
Inhibitors of protein phosphatase-2A from human brain structures, immunocytological localization and activities towards dephosphorylation of the Alzheimer type hyperphosphorylated tau.
Tsujio I, Zaidi T, Xu J, Kotula L, Grundke-Iqbal I, Iqbal K
FEBS letters 2005 Jan 17;579(2):363-72
FEBS letters 2005 Jan 17;579(2):363-72
Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor.
Fan Z, Beresford PJ, Oh DY, Zhang D, Lieberman J
Cell 2003 Mar 7;112(5):659-72
Cell 2003 Mar 7;112(5):659-72
Identification and characterization of SEB, a novel protein that binds to the acute undifferentiated leukemia-associated protein SET.
Minakuchi M, Kakazu N, Gorrin-Rivas MJ, Abe T, Copeland TD, Ueda K, Adachi Y
European journal of biochemistry / FEBS 2001 Mar;268(5):1340-51
European journal of biochemistry / FEBS 2001 Mar;268(5):1340-51
Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein.
Seo SB, McNamara P, Heo S, Turner A, Lane WS, Chakravarti D
Cell 2001 Jan 12;104(1):119-30
Cell 2001 Jan 12;104(1):119-30
Molecular identification of I1PP2A, a novel potent heat-stable inhibitor protein of protein phosphatase 2A.
Li M, Makkinje A, Damuni Z
Biochemistry 1996 Jun 4;35(22):6998-7002
Biochemistry 1996 Jun 4;35(22):6998-7002
Replication factor encoded by a putative oncogene, set, associated with myeloid leukemogenesis.
Nagata K, Kawase H, Handa H, Yano K, Yamasaki M, Ishimi Y, Okuda A, Kikuchi A, Matsumoto K
Proceedings of the National Academy of Sciences of the United States of America 1995 May 9;92(10):4279-83
Proceedings of the National Academy of Sciences of the United States of America 1995 May 9;92(10):4279-83
Can, a putative oncogene associated with myeloid leukemogenesis, may be activated by fusion of its 3' half to different genes: characterization of the set gene.
von Lindern M, van Baal S, Wiegant J, Raap A, Hagemeijer A, Grosveld G
Molecular and cellular biology 1992 Aug;12(8):3346-55
Molecular and cellular biology 1992 Aug;12(8):3346-55
No comments: Submit comment
No validations: Submit validation data